FEDERAL COURT OF AUSTRALIA
PhotoCure ASA v Queen’s University at Kingston [2005] FCA 344
PATENTS – invention claimed for a method of detection and treatment of malignant and non-malignant lesions by photochemotherapy – whether patent invalid on grounds of obviousness, lack of novelty, lack of sufficiency and best method, lack of definition or lack of fair basis – whether the patent is infringed in substance by a variant that does not have a material effect on the way the invention works – consideration of the principles to be applied in determining a claim of infringement in substance when no claim is infringed on a textual approach to construction of the patent
Patents Act 1990 (Cth) ss 7, 40(2)(a), 40(2)(b), 117, 138(3)(b) and 234 and Sch 1
Patents Act 1952 (Cth) s 100(1)(e)Amadio Pty Ltd v Henderson (1998) 81 FCR 149
Minnesota Mining & Manufacturing Co v Tyco Electronics Pty Ltd (2002) 56 IPR 248
NV Philips Gloeilampenfabrieken v Mirabella International Pty Ltd (1993) 44 FCR 239
Aktiebolaget Hässle v Alphapharm Pty Limited (2002) 212 CLR 411
General Tire & Rubber Company v The Firestone Tyre and Rubber Company Ltd [1972] RPC 457
The Leonardis v Sartas No 1 Pty Ltd (1996) 67 FCR 126
ICI Chemicals & Polymers Ltd v Lubrizol Corporation Inc (1999) 45 IPR 577
Minnesota Mining and Manufacturing Co v Beiersdorf (Australia) Ltd (1980) 144 CLR 253
Aktiebolaget Hässle v Alphapharm Pty Ltd (2000) 51 IPR 375
Aktiebolaget Hässle v Alphapharm Pty Ltd (1999) 44 IPR 593
Williams Advanced Materials, Inc v Target Technology Company LLC [2004] FCA 1405
Nescor Industries Group Pty Ltd v Miba Pty Ltd (1997) 150 ALR 633
Chiron Corporation v Organon Teknika Ltd (No 3) [1994] FSR 202
ICI Chemicals & Polymers Ltd v The Lubrizol Corporation Inc (2000) 106 FCR 214
Meyers Taylor Pty Ltd v Vicarr Industries Ltd (1977) 137 CLR 228
R D Werner & Co Inc v Bailey Aluminium Products Pty Ltd (1989) 25 FCR 565
Bristol-Myers Squibb Company v FH Faulding & Co Ltd (2000) 97 FCR 524
Nicaro Holdings Pty Ltd v Martin Engineering Co (1990) 91 ALR 513
Hills v Evans (1862) 31 LJ Ch 457
Olin Corporation v Super Cartridge Co. Pty Ltd (1977) 180 CLR 236
Arrow Pharmaceuticals Ltd v Merck & Co Inc (2004) 213 ALR 182
Rescare Ltd v Anaesthetic Supplies Pty Ltd (1992) 111 ALR 205
Kimberly-Clark Australia Pty Limited v Arico Trading International Pty Limited (2001) 207 CLR 1
Innovative Agriculture Products Pty Ltd v Cranshaw (1996) 35 IPR 643
Electric & Musical Industries Ltd v Lissen Ltd [1938] 4 All ER 221
Welch Perrin and Company Pty Ltd v Worrel (1961) 106 CLR 588
Kauzal v Lee (1936) 58 CLR 670
Raleigh Cycle Co Ltd v H Miller & Co Ltd [1948] 1 All ER 308
General Steel Industries Inc v State of New South Wales (1967) 40 ALJR 464
Windsurfing International Inc v Petit [1984] 2 NSWLR 196
Philpott v Hanbury (1885) 2 RPC 33
Rose…
Keep reading for free
Create a free CaseChat account to read PhotoCure ASA v Queen's University at Kingston and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2005] FCA 344
- Decision Date
CaseChat Overview and Summary
The court found that the patent was valid and that DUSA had not infringed PhotoCure's patent rights. The court held that the terms "administering to the patient" and "5-aminolevulinic acid" had their primary meanings within the claims, and that compliance with these terms was an essential requirement of the invention. The court also found that the claimed invention was not obvious in light of the prior art. The court noted that the prior art disclosed the use of porphyrins for PDT, but did not disclose the use of 5-aminolevulinic acid, which was a key component of the claimed invention. The court further found that the claimed invention was not obvious to a person skilled in the art, as it required a specific combination of elements that were not suggested or taught by the prior art.
In conclusion, the court dismissed PhotoCure's application to revoke the patent and DUSA's cross-claim for infringement. The court held that each party was to bear its own costs of and incidental to the application and cross-claim. The court found that the patent was valid and that DUSA had not infringed PhotoCure's patent rights. The court also held that the claimed invention was not obvious in light of the prior art, and that the terms within the claims had their primary meanings.
Orders
Orders of the court
1. The application and the cross-claim be dismissed.
2. Each of the parties is to bear its own costs of and incidental to the application and cross-claim.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Established by: MERKEL J